Bardeloza, John Daniel .

HRN: 28-62-05  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2026
CEFUROXIME 1.5GM (VIAL)
02/23/2026
03/02/2026
IV
430mg
Q8h
Pcap C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: